(Q44226007)

1 December 2017

Intravenous ribavirin and hyperammonemia in an immunocompromised patient infected with adenovirus (English)

1 reference

1 December 2017

1 reference

1 reference

4

Tzakis A

1 reference

1 December 2017

Bertrand P

1

1 reference

1 December 2017

Faro A

series ordinal

2

1 reference

1 December 2017

Cantwell P

series ordinal

3

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

1 December 2017

1 reference

1 December 2017

20

1 reference

1 December 2017

10

1 reference

1 December 2017

1216-1220

1 reference

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide

1 December 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.15.1216.34582

Lassa fever. Effective therapy with ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.15.1216.34582

Prospective, Double-Blind, Concurrent, Placebo-Controlled Clinical Trial of Intravenous Ribavirin Therapy of Hemorrhagic Fever with Renal Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.15.1216.34582

Adenovirus infections in patients undergoing bone-marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.15.1216.34582

Effects of ribavirin on red blood cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.15.1216.34582

Diet- and valproate-induced transient hyperammonemia: effect of L-carnitine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.15.1216.34582

10.1592/PHCO.20.15.1216.34582

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference